Thu, Sep 18, 2014, 7:15 AM EDT - U.S. Markets open in 2 hrs 15 mins


% | $
Quotes you view appear here for quick access.

ImmunoCellular Therapeutics, Ltd. Message Board

  • the_7_th_raven the_7_th_raven Aug 14, 2012 10:33 AM Flag


    Pardon my ignorance but where is all the money to sustain this company coming from?

    Someone has to be giving them credit. In the business world nobody does this without expecting payback.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • common financing with most developmental biotechs. the company looks to have around 12 months of cash available based on current burn rate. i am anticipating a partner or licensing deal with interim p2 data, which could be in the next several months, although the better the treatment is working it could mean a longer timeframe.
      the real key to reading the financials are the lack of short and long term debt. that usually buries companies that cant get favorable terms when financing is needed.

0.97+0.08(+8.99%)Sep 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.